Key facts
- This page summarizes Michael Harsh's Form 4 filing for ENDRA Life Sciences Inc. (NDRA).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Jan 2026, 19:43.
Michael Harsh - 21 Jan 2026 Form 4 Insider Report for ENDRA Life Sciences Inc. (NDRA)
- Reporting relationship
- Director
- Issuer ticker
- NDRA
- Reported as of
- 21 Jan 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 23 Jan 2026, 19:43:37 UTC
- Prior SEC filing
- 01 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Harsh by Mark Busch, attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael Harsh filed Form 4 for ENDRA Life Sciences Inc. (NDRA) on 23 Jan 2026.
Change
- Previous filing in this sequence was filed on 01 Jul 2025.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001706155
Primary reporting owner
Harsh Michael
- Relationship
- Director
- Address
- C/O ENDRA LIFE SCIENCES INC., 3600 GREEN COURT, SUITE 350, ANN ARBOR
- Signature
- /s/ Michael Harsh by Mark Busch, attorney-in-fact
- Signature date
- 23 Jan 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NDRA
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +60,324
- Change %
- +1120%
- Price
- $0.000000
- Shares after
- 65,710
- Date
- 21 Jan 2026
- Ownership
- Direct
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Holdings include unvested restricted stock units ("RSUs").
Footnote F2
Represents RSUs that convert to common stock on a one-for-one basis. The RSUs will vest in full on January 21, 2026.